Sources | Names Used |
---|---|
CTRPv2 | BRD-K03911514 |
PharmacoGx | BRD-K03911514 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRWD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
mRNA | VSTM2B | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0008 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
mRNA | FRRS1 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
mRNA | MYO3A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
mRNA | RP1-309K20.6 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0008 |
mRNA | PRSS23 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0008 |
mRNA | LUZP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
mRNA | ANO10 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0009 |